echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The field research group has made new progress in the application of novel photothermal nanomaterials to diabetic wound healing

    The field research group has made new progress in the application of novel photothermal nanomaterials to diabetic wound healing

    • Last Update: 2022-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Recently, Advanced Healthcare Materials (Advanced Health Materials, IF=11.
    092
    ) published online the research results
    of the field research group of the School of Pharmacy of Wuhan University and the Institute of Pharmacy of Zhongnan Hospital in the treatment of bacterial infections with photothermal materials 。 In this study, a supramolecular self-assembled nanomaterial based on chitosan and carburyxin photosensitizer was designed and developed, which realized effective bacterial capture and photothermal synergy antibacterial, which significantly promoted the healing
    of diabetic infected wounds.

    The paper is "Self-assembled Corrole/Chitosan photothermal nanoparticles for accelerating infected diabetic wound healing.
    "
    Chitosan photothermal nanoparticles accelerate wound healing in diabetic infection").

    Yu Yunhao, a 2020 master student at the School of Pharmacy of Wuhan University, is the first author, and Yang Yingwei, professor of the School of Chemistry of Wuhan University and Jilin University, is the co-corresponding author
    .
    Wuhan University is the first signature and newsletter
    of the paper.

    Bacterial infection is one of the leading causes of human death, among which the microvascular dysfunction caused by hyperglycemia in diabetic patients leads to slow healing of diabetic wounds, which significantly increases the risk of
    bacterial infection in the wound healing process.
    At present, antibiotics are the most commonly used drugs
    to deal with bacterial infections in clinical treatment.
    However, the inappropriate use of antibiotics has led to the emergence of multidrug-resistant strains such as methicillin-resistant Staphylococcus aureus
    (MRSA), which severely inhibits the therapeutic effect
    of antibiotics.
    Therefore, the development of drug-resistant antimicrobials and strategies is essential
    for the management of infectious wounds in patients with diabetes.

    In view of this, the field research group used carbrole photosensitizer and chitosan as monomers, and induced the self-assembly of clickrole molecules with hydrogen bonding and π-π accumulation to form novel supramolecular photothermal nanoparticles (MCC/CS NPs) by using caction photosensitizer and chitosan as monomers to treat bacterial wound infection and promote the healing
    of chronic wounds.
    In this core-shell supramolecular nanosystem, the core cuckrole molecules can significantly quench molecular fluorescence emission in a highly aggregated state
    , produce excellent photothermal performance under 660 nm laser irradiation, and achieve photothermal conversion efficiency of up to 66.
    4%,
    while the protonated chitosan shell has an intrinsic antibacterial effect
    。 In addition, the positively charged surface of this nanoparticle can selectively target negatively charged bacteria through electrostatic interaction, producing a powerful photothermal antibacterial and inherent antibacterial synergy against E.
    coli and methicillin-resistant Staphylococcus aureus under laser irradiation
    .
    The team further confirmed that supramolecular photothermal nanoparticles can effectively kill drug-resistant bacteria, accelerate wound healing and angiogenesis, and have good biocompatibility, showing great potential
    as broad-spectrum photothermal antibacterial nanoplatforms.
    In addition, the supramolecular nanosystem is simple in composition and easy to prepare, which has the promise
    of further clinical translational research.

    The research was supported
    by the National Natural Science Foundation of China, the Basic Research Fund of the Central Universities, and the post-grant project of the Wuhan Center for Infectious Diseases and Oncology Research of the Chinese Academy of Medical Sciences.

     

    Links to papers: https://doi.
    org/10.
    1002/adhm.
    202201651

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.